BRCA1-regulated RRM2 expression protects glioblastoma cells from endogenous replication stress and promotes tumorigenicity
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
BRCA1-regulated RRM2 expression protects glioblastoma cells from endogenous replication stress and promotes tumorigenicity. / Rasmussen, Rikke D.; Gajjar, Madhavsai K.; Tuckova, Lucie; Jensen, Kamilla E; Maya-Mendoza, Apolinar; Holst, Camilla B.; Mollgaard, Kjeld; Rasmussen, Jane S.; Brennum, Jannick; Bartek, Jiri, Jr.; Syrucek, Martin; Sedlakova, Eva; Andersen, Klaus K.; Frederiksen, Marie H.; Bartek, Jiri; Hamerlik, Petra.
In: Nature Communications, Vol. 7, 13398, 15.11.2016.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - BRCA1-regulated RRM2 expression protects glioblastoma cells from endogenous replication stress and promotes tumorigenicity
AU - Rasmussen, Rikke D.
AU - Gajjar, Madhavsai K.
AU - Tuckova, Lucie
AU - Jensen, Kamilla E
AU - Maya-Mendoza, Apolinar
AU - Holst, Camilla B.
AU - Mollgaard, Kjeld
AU - Rasmussen, Jane S.
AU - Brennum, Jannick
AU - Bartek, Jiri, Jr.
AU - Syrucek, Martin
AU - Sedlakova, Eva
AU - Andersen, Klaus K.
AU - Frederiksen, Marie H.
AU - Bartek, Jiri
AU - Hamerlik, Petra
PY - 2016/11/15
Y1 - 2016/11/15
N2 - Oncogene-evoked replication stress (RS) fuels genomic instability in diverse cancer types. Here we report that BRCA1, traditionally regarded a tumour suppressor, plays an unexpected tumour-promoting role in glioblastoma (GBM), safeguarding a protective response to supraphysiological RS levels. Higher BRCA1 positivity is associated with shorter survival of glioma patients and the abrogation of BRCA1 function in GBM enhances RS, DNA damage (DD) accumulation and impairs tumour growth. Mechanistically, we identify a novel role of BRCA1 as a transcriptional co-activator of RRM2 (catalytic subunit of ribonucleotide reductase), whereby BRCA1-mediated RRM2 expression protects GBM cells from endogenous RS, DD and apoptosis. Notably, we show that treatment with a RRM2 inhibitor triapine reproduces the BRCA1-depletion GBM-repressive phenotypes and sensitizes GBM cells to PARP inhibition. We propose that GBM cells are addicted to the RS-protective role of the BRCA1-RRM2 axis, targeting of which may represent a novel paradigm for therapeutic intervention in GBM.
AB - Oncogene-evoked replication stress (RS) fuels genomic instability in diverse cancer types. Here we report that BRCA1, traditionally regarded a tumour suppressor, plays an unexpected tumour-promoting role in glioblastoma (GBM), safeguarding a protective response to supraphysiological RS levels. Higher BRCA1 positivity is associated with shorter survival of glioma patients and the abrogation of BRCA1 function in GBM enhances RS, DNA damage (DD) accumulation and impairs tumour growth. Mechanistically, we identify a novel role of BRCA1 as a transcriptional co-activator of RRM2 (catalytic subunit of ribonucleotide reductase), whereby BRCA1-mediated RRM2 expression protects GBM cells from endogenous RS, DD and apoptosis. Notably, we show that treatment with a RRM2 inhibitor triapine reproduces the BRCA1-depletion GBM-repressive phenotypes and sensitizes GBM cells to PARP inhibition. We propose that GBM cells are addicted to the RS-protective role of the BRCA1-RRM2 axis, targeting of which may represent a novel paradigm for therapeutic intervention in GBM.
UR - https://www.nature.com/articles/s41467-018-07892-6
U2 - 10.1038/ncomms13398
DO - 10.1038/ncomms13398
M3 - Journal article
C2 - 27845331
VL - 7
JO - Nature Communications
JF - Nature Communications
SN - 2041-1723
M1 - 13398
ER -
ID: 169943448